Macrophage in idiopathic pulmonary fibrosis : effets of Nintedanib and expression of the prognostic biomarker CXCL13
Nessrine Bellamri(Inserm)
theses.fr (ABES)
December 18, 2019
Cited by 0
Related Papers
Alteration of human macrophage phenotypes by the anti-fibrotic drug nintedanib
|International Immunopharmacology|2019|63
Effects of Ruxolitinib on fibrosis in preclinical models of systemic sclerosis
|International Immunopharmacology|2023|26
Le macrophage dans la fibrose pulmonaire idiopathique : effets du nintédanib et expression du biomarqueur pronostique CXCL13
|ORI-OAI warehouse (University of Rennes)|2019|0